Adam O'Dell left medical school over 20 years ago. He's been showing readers winning trades ever since — including a recent play on Adaptive Biotechnologies that has gone as high as 280% in just 24 months.
Today, he's revealing his top biotech stock to own right now.
In his words: "This tiny Boston-based AI biotech holds 179 patents on a medical breakthrough I expect to blossom into a $1 trillion industry. Its shares won't trade under $5 for long.”
Crude oil prices have retreated below $100 per barrel, and investors are seeing signs that the Strait of Hormuz — the narrow passage through which roughly a fifth of the world’s oil flows — might be opening. But Adam O’Dell warns that attempting to trade the headlines is a risky game where you’re very likely to get whipsawed. What should you do instead? Click here to find out.
Tim Sykes’ student Jack Kellogg turned $7,000 into over $27 million in verified trading profits. Last year alone, he averaged $25,722 per day. Jack didn’t have a financial background, and he had zero trading experience. So how did he do it? And what would he do if he had to start over today? Click here for the full story.
The United States has been conducting what the Pentagon politely calls an “operation” against Iranian military infrastructure. Because of this, the Strait of Hormuz has become a chessboard of tankers, mines and nervous insurance underwriters. Addison Wiggin observes that it’s also impacting the five dominant trends shaping the market today. What are they? Click here for the details.
(c) 2026 Banyan Hill Publishing. All Rights Reserved. Protected by copyright laws of the United States and international treaties. This Newsletter may only be used pursuant to the subscription agreement. Any reproduction, copying, or redistribution, (electronic or otherwise) in whole or in part, is strictly prohibited without the express written permission of Banyan Hill Publishing. 702 Cathedral Street, Baltimore, MD 21201. (TEL: 866-584-4096) Legal Notice
The mailbox associated with this email address is not monitored, so please do not reply.
Your feedback is very important to us so if you would like to contact us with a question or comment, please click here.
Post a Comment
Post a Comment